Table 6.
Adjustable stimulation
(N = 33) |
Preset stimulation
(N = 17) |
Medically managed
(N = 17) |
Ancillary
(N = 8) |
|||||
---|---|---|---|---|---|---|---|---|
Preferred term | No. of subjects | Percentage of subjects | No. of subjects | Percentage of subjects | No. of subjects | Percentage of subjects | No. of subjects | Percentage of subjects |
Migraine | 3 | (9.1%) | 7 | (41.2%) | 4 | (23.5%) | 0 | (0.0%) |
Drug toxicity | 3 | (9.1%) | 2 | (11.8%) | 0 | (0.0%) | 1 | (12.5%) |
Headache | 1 | (3.0%) | 2 | (11.8%) | 0 | (0.0%) | 1 | (12.5%) |
Adverse drug reaction | 1 | (3.0%) | 1 | (5.9%) | 1 | (5.9%) | 0 | (0.0%) |
Sinusitis | 0 | (0.0%) | 1 | (5.9%) | 1 | (5.9%) | 1 | (12.5%) |
Anxiety | 1 | (3.0%) | 0 | (0.0%) | 1 | (5.9%) | 0 | (0.0%) |
Bronchitis | 1 | (3.0%) | 1 | (5.9%) | 0 | (0.0%) | 0 | (0.0%) |
Depression | 2 | (6.1%) | 0 | (0.0%) | 0 | (0.0%) | 0 | (0.0%) |
Dizziness | 0 | (0.0%) | 1 | (5.9%) | 0 | (0.0%) | 1 | (12.5%) |
Fall | 2 | (6.1%) | 0 | (0.0%) | 0 | (0.0%) | 0 | (0.0%) |
Fungal infection | 0 | (0.0%) | 2 | (11.8%) | 0 | (0.0%) | 0 | (0.0%) |
Hypothyroidism | 0 | (0.0%) | 2 | (11.8%) | 0 | (0.0%) | 0 | (0.0%) |
Lymphadenopathy | 1 | (3.0%) | 1 | (5.9%) | 0 | (0.0%) | 0 | (0.0%) |
Sinus headache | 1 | (3.0%) | 0 | (0.0%) | 1 | (5.9%) | 0 | (0.0%) |
Upper respiratory tract infection | 0 | (0.0%) | 1 | (5.9%) | 1 | (5.9%) | 0 | (0.0%) |
Total† | 17 | (52%) | 13 | (76%) | 9 | (53%) | 6 | (75%) |
Adverse events reported in more than one subject.
“Total” row includes all events, including those reported in only one subject.